Related Experiment Video
Updated: Oct 29, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Biologic therapy: A paradigm shift in asthma management
1Mara Thrasher is an NP at the Allergy, Asthma, and Immunology Center in East Tennessee.
Abstract:
Biologic medications provide opportunities to improve the health, safety, quality of life, and long-term outcomes of patients with moderate-to-severe uncontrolled asthma. This article provides primary care nurse practitioners with an overview of the pathophysiology of Type 2 inflammation in asthma, the mechanism of action of biologics approved for asthma, monitoring considerations, and practice considerations.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
COPD: Management Using Bronchodilators and Corticosteroids
Asthma-IV: Nursing Management
First, in...
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: